Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Anal Canal Carcinoma × Radiotherapy, Intensity-Modulated × Clear all

Phase

Phase 2 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 10 Head and Neck Neoplasms 8 Breast Neoplasms 7 Nasopharyngeal Carcinoma 6 Neoplasm Metastasis 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Oropharyngeal Neoplasms 4 Urinary Bladder Neoplasms 3 Radiation Injuries 3 Neoplasms 3 Glioma 3 Carcinoma, Squamous Cell 3 Brain Neoplasms 3 Sarcoma, Ewing 2 Sarcoma 2 Rectal Neoplasms 2 Nasopharyngeal Neoplasms 2 Mesothelioma, Malignant 2 Meningeal Carcinomatosis 2 Glioblastoma 2 Wilms Tumor 1 Virus Diseases 1 Tumor Virus Infections 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Stage IA Uterine Sarcoma 1 Sinonasal undifferentiated carcinoma 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1

Interventions

Radiotherapy, Intensity-Modulated 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06630793 2025-04-08

IMPAC

Tata Memorial Centre

Phase NA Recruiting

Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡